Financhill
Back

Pacira BioSciences Vs. Cyclo Therapeutics Industry Stock Comparison

Sell
47

PCRX
Pacira BioSciences

Last Price:
19.89
Seasonality Move:
12.01%
Sell
31

CYTH
Cyclo Therapeutics

Last Price:
0.59
Seasonality Move:
18.97%
Sell
47
Pacira BioSciences (PCRX) is a Sell

Is Pacira BioSciences a Buy, Sell or Hold?

  • The current Pacira BioSciences [PCRX] share price is $19.86. The Score for PCRX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • PCRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
Cyclo Therapeutics (CYTH) is a Sell

Is Cyclo Therapeutics a Buy, Sell or Hold?

  • The current Cyclo Therapeutics [CYTH] share price is $0.58. The Score for CYTH is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • CYTH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PCRX Stock Price Chart

What is Pacira BioSciences's stock price today?

  • The Pacira BioSciences share price today is $19.86
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PCRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

CYTH Stock Price Chart

What is Cyclo Therapeutics's stock price today?

  • The Cyclo Therapeutics share price today is $0.58
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTH is experiencing slight selling pressure.

PCRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.83 Buy
Relative Strength Index (14 RSI): 64.1 Buy
Chaikin Money Flow: 553961 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.53 - 19.03) Buy
Bollinger Bands (100): (14.02 - 18.88) Buy

CYTH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 37.49 Sell
Chaikin Money Flow: -14999 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.62 - 0.72) Sell
Bollinger Bands (100): (0.62 - 1) Sell

PCRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.48 Buy
20-day SMA: 18 Buy
50-day SMA: 17.25 Buy
200-day SMA: 22.02 Sell
8-day EMA: 19.34 Buy
20-day EMA: 18.4 Buy
50-day EMA: 17.55 Buy
200-day EMA: 21.38 Sell

CYTH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.61 Sell
20-day SMA: 0.66 Sell
50-day SMA: 0.71 Sell
200-day SMA: 1.08 Sell
8-day EMA: 0.61 Sell
20-day EMA: 0.65 Sell
50-day EMA: 0.71 Sell
200-day EMA: 1 Sell

Pacira BioSciences Earnings Growth & PCRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.19 per share, and a decrease next year of $0.19 per share.

Cyclo Therapeutics Earnings Growth & CYTH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Pacira BioSciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cyclo Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):